Although modest, the reduction in LDL-C, IP-10 and MCP-1 suggest a favorable milieu for vascular function potentially reducing the development/progression of atherosclerosis, which has been reported in ~11% of servicemembers with no cardiovascular risk factors and as high as 50% in those with dyslipidemia [44]. The gene discussed is CCL2; the disease is metabolic syndrome.